Materias dentro de su búsqueda.
Mostrando 35,981 - 36,000 Resultados de 36,131 Para Buscar 'yecla~', tiempo de consulta: 1.54s Limitar resultados
  1. 35981
    “…DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
  2. 35982
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review
  3. 35983
    “…Additionally, while TO and VO visits are temporarily equally reimbursed as in person visits under the U.S government's COVID emergency declaration, there has already been a return to markedly lower reimbursement for TO visits. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association of Race, Ethnicity, Age and Socioeconomic Status with Access to Virtual Visits within the Brigham & Women's Hospital Division of Hematology during the COVID-19 Pandemic
  4. 35984
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
  5. 35985
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
  6. 35986
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Outcomes in Critically-Ill Patients with COVID-19 Treated with Therapeutic Dose of Anticoagulants for Suspected Thromboembolism
  7. 35987
    “…This study was conducted in accordance with the Declaration of Helsinki, and approved by the ethics committee of our institution. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients
  8. 35988
    “…DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura
  9. 35989
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19
  10. 35990
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome
  11. 35991
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare. OFFLABEL DISCLOSURE: Booster vaccination (after full vaccination) using BNT162b2, mRNA-1273, or Ad26.COV2.S…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination - Observational Data from the LLS National Registry
  12. 35992
    “…[Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patients with Hodgkin Lymphoma Develop Adequate Humoral Serological Response to Vaccination with Two Doses of BNT162b2
  13. 35993
    “…The funders had no role in study design, data collection and analysis, publishing or preparation of the manuscript. The authors declare no conflicts of interest.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome
  14. 35994
    por Harrison, C, Boivin, J, Gameiro, S
    Publicado 2022
    “…Dr S.G. reports consultancy fees from Ferring Pharmaceuticals A/S, Access Fertility and SONA-Pharm LLC, and grants from Merck Serono Ltd, an affiliate of Merck KGaA, Darmstadt, Germany. Dr C.H. declares no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning: qualitative investigation of multi-cycle planning and its acceptability to patients and staff
  15. 35995
    “…The authors have no conflicts of interest to declare in relation to the contents of this work. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Selective loss of kisspeptin signaling in oocytes causes progressive premature ovulatory failure
  16. 35996
    “…STUDY FUNDING/COMPETING INTEREST(S): The work was funded by the Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The impact of maternal smoking on embryonic morphological development: the Rotterdam Periconception Cohort
  17. 35997
    “…Mots clés contrôle qualité ; monitoring ; consentement ; promotion Déclaration de liens d'intérêts Les auteurs n'ont pas précisé leurs éventuels liens d'intérêts…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assurer le contrôle qualité d'un essai clinique pendant la pandémie de COVID-19 : l'expérience de l'étude Inserm C20-15 DisCoVeRy en France
  18. 35998
    “…Mots clés lupus éruthémateux disséminé ; manifestations respiratoires ; anxiété ; dépression ; qualité de vie Déclaration de liens d'intérêts Les auteurs n'ont pas précisé leurs éventuels liens d'intérêts…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact des manifestations respiratoires du lupus érythémateux disséminé sur la qualité de vie et l’état psychologique des patients lors de la pandémie du COVID19
  19. 35999
    “…The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Maternal and obstetric outcomes are influenced by developmental stage and cryopreservation of transferred embryos after clomiphene citrate-based minimal stimulation IVF
  20. 36000
    “…Cette surcharge économique devrait être réduite avec la mise en place de la couverture vaccinale en 2021. LIENS D'INTÉRÊTS DÉCLARÉS: Pr Sébastien Gallien : membre du comité scientifique de cette étude, qui est financée par Janssen-cilag France…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Coûts des hospitalisations et des soins de suite et de réadaptation liés au COVID-19 en France en 2020
Herramientas de búsqueda: RSS